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The results from a subchronic feeding study conducted in Sprague–Dawley rats fed with diets containing
grain from 4114 (OECD unique identiﬁer: DP-ØØ4114-3) maize that was untreated (4114) or sprayed in
ﬁeld with glufosinate ammonium (4114GLU) in a design similar to previous studies are reported. The test
material, 4114 maize, is a hybrid maize produced by transformation with a DNA construct encoding 4
different transgenic proteins for resistance to lepidopteran pests, coleopteran pests, and tolerance to
the herbicidal active ingredient glufosinate ammonium. There were a total of 144 rats divided into 12
groups of 12 rats/sex/group. All experimental diets were formulated by Purina Mills, LLC (St. Louis,
MO) in accordance with the standards of Purina Mills Labdiet Certiﬁed Rodent LabDiet 5002. The incor-
poration rate of maize grain in all diets was 32% (wt/wt). No biologically signiﬁcant, treatment related
differences in body weight, food consumption, clinical pathology parameters (hematology, blood chem-
istry, urinalysis, or organ weight) were observed in rats consuming the diets containing 4114 maize grain
compared with rats fed conventional maize diets. A number of histologic observations were noted in this
study but were background lesions and representative of what would be expected for rats of this age and
strain. An independent panel of experts determined certain observations to be spontaneous and not
related to the test diet. Accordingly, these results support the conclusion that 4114 maize grain is as safe
and nutritious as conventional maize grain.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Biotechnology has been used to introduce traits such as insect
resistance and herbicide tolerance into ﬁeld crops by transforma-
tion with DNA constructs that drive expression of transgenic pro-
teins. Since the mid 1990s, a signiﬁcant number of biotech crops
containing an assortment of insecticidal proteins from the ubiqui-
tous soil bacteria Bacillus thuringiensis (Bt proteins) have been
introduced into the market. Increasingly, farmers have chosen to
plant insect control traits in combination with various herbicide-
tolerance traits for improved insect and weed control. Biotech
crops have revolutionized agriculture, with high levels of adoption
in the USA and around the globe that provide economic gains for
farmers, along with substantial environmental beneﬁts. Prior to
commercialization, the introduced proteins in genetically modiﬁed
(GM) plants are subjected to rigorous testing to ensure that they
are not allergenic or toxic (Codex, 2003; Delaney et al., 2008). Fol-
lowing transformation and selection, crops containing theternational, Inc., 2450 SE Oak
086; fax: +1 515 535 7278.
laney).
C-ND license. transgenic proteins are also subjected to a comprehensive safety
assessment based on the concept of substantial equivalence
(WHO, 1991, 1995). This has more recently been described as a
comparative safety assessment as the focus is on demonstrating
that any particular GM crop is ‘‘as safe as’’ its closest conventional
non-GM comparator with a history of safe use (FAO, 2008). This in-
cludes compositional and agronomic performance comparisons to
determine whether the development of a particular GM crop re-
sulted in unintended effects (Herman et al., 2003; McCann et al.,
2007; Ridley et al., 2002; Sidhu et al., 2000). Subchronic rodent
feeding studies have also been conducted in support of the safety
assessment process for a number of individual corn and soybean
GM crops (Hammond et al., 2006a,b, 2004; MacKenzie et al.,
2007; Malley et al., 2007; Appenzeller et al., 2008; He et al.,
2008; Healy et al., 2008). To date, these studies have not identiﬁed
test diet related adverse effects following dietary exposure to
whole grains from commercialized GM crops.
Crop plants with multiple transgenic traits have been developed
using breeding methods to cross individual GM lines. Because no
new DNA is introduced when crossing a safety assessed GM crop
with another safety assessed GM crop additional safety testing
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considered unnecessary (ACRE, 2004; De Schrijver et al., 2007; Pil-
acinski et al., 2011). This is supported by compositional studies
(Ridley et al., 2011) as well as feeding studies conducted in rats
(Appenzeller et al., 2009) and in livestock species (Taylor et al.,
2003a,b,c). It is also possible to introduce multiple traits into a ﬁeld
crop through design of multigene vectors that express more than
one transgenic protein, referred to as molecular stacking (see
Que et al., 2010).
The current paper reports the results of a subchronic rodent
feeding study that was conducted with maize grain obtained from
a GM hybrid corn (DP-ØØ4114-3; hereafter referred to as 4114
maize). The transformation plasmid used to produce 4114 maize
was designed to express: (i) Cry1F protein for resistance to Euro-
pean corn borers (ECB; Ostrinia nubilalis Hübner: Crambidae) and
other lepidopteran pests; (ii) Cry34Ab1 and Cry35Ab1 proteins
for resistance to corn rootworms and other coleopteran pests
(CRW; Diabrotica virgifera virgifera LeConte and Diabrotica barberi
Smith and Lawrence); and (iii) the PAT protein for tolerance to
the herbicidal active ingredient glufosinate ammonium. The Cry
proteins demonstrate species selective toxicity via pore formation
within the gut of sensitive larvae (Piggot and Ellar, 2007; CERA,
2011). The PAT protein detoxiﬁes glufosinate via N-acetylation
thereby preventing it from inhibiting glutamine synthase which
is a critical enzyme required to detoxify ammonia produced during
photorespiration and other cellular activities (De Block et al.,
1987). None of these proteins are allergenic or toxic (Herman
et al., 2003; Hérouet et al., 2005; Ladics et al., 2006; Delaney
et al., 2008; Juberg et al., 2009) and no test diet related adverse ef-
fects were observed in rodent studies conducted with grain from
individual GM hybrid crops in which these proteins were ex-
pressed (MacKenzie et al., 2007; Malley et al., 2007; He et al.,
2008). Similarly, no evidence of test diet related adverse effects
was observed in a subchronic feeding study conducted with grain
from a GM maize plant produced through conventional breeding
containing all four proteins (Appenzeller et al., 2009). The current
study was conducted to support the safety of grain obtained from
4114 maize.
This study was conducted in accordance with OECD guidelines
(No. 408; OECD, 1998) for 13 week repeated dose toxicology stud-
ies in a facility accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care International (AAALAC).
The protocol and study design were reviewed and approved by
the DuPont Haskell Institutional Animal Care and Use Committee
(IACUC).
In the course of conducting the histopathologic analysis of the
tissues slides from this study, amphophilic vacuolar (AV) kidney
tumors were observed in two male rats from the group consuming
test diet containing grain from 4114 maize. An expert panel of tox-
icologic pathologists was assembled (Pathology Working Group) to
review the tissue slides for purposes of classiﬁcation and they
determined unanimously that the AV tumors were spontaneous
and not test diet related. The detailed methods and tissue slides
are presented in the accompanying publication (Hardisty et al.,
submitted for publication).2. Materials and methods
2.1. Production and analytical characterization of maize grains
4114 maize grain from glufosinate-treated plants (4114GLU) and non-glufosi-
nate-treated plants (4114), non-GM near-isogenic control maize grain (091), and
commercially available non-GM hybrid reference maize grains (32D78, 33N29,
and 34P88) were grown in isolated ﬁeld plots in York, Nebraska in the 2010 grow-
ing season. The identities of the maize grains used in this study were conﬁrmed
using event speciﬁc qualitative polymerase chain reaction (PCR) methods for the
presence or absence of event DP-ØØ4114-3 and the presence and concentrationsof the Cry34Ab1, Cry35Ab1, Cry1F and PAT proteins using antibody speciﬁc en-
zyme-linked immunosorbant assay (ELISA) (Pioneer Hi-Bred International, Inc. Ank-
eny, IA). Maize grain composition of nutritional proximates, carbohydrates, ﬁber
values, individual amino acids, fatty acids, vitamins, minerals, anti-nutrients and
secondary metabolites were determined as previously described (Appenzeller et
al., 2009) at EPL-BioAnalytical Services, Inc. (EPL-BAS; Niantic, IL). Additional fatty
acid composition (caprylic, capric, lauric, myristic, myristoleic, pentadecanoic, pen-
tadecenoic, palmitoleic, heptadecanoic, heptadecenoic, heptadecadienoic, C18:2
(9,15), nonadecanoic, arachidic, eicosenoic, eicosadienoic, eicosatrienoic, aracha-
donic, heneicosanoic, behenic, erucic, tricosanoic and lignoceric [percentage of total
fatty acids]) and the concentrations of pantothenic acid (mg/100 g), pyridoxine
(mg/100 g) and niacin (mg/100 g) were determined by EPL-BAS. Selenium concen-
tration (ppm) was determined by Euroﬁns Scientiﬁc, Inc. (Des Moines, IA). Chlori-
nated hydrocarbon residues and organophosphates were determined at Columbia
Food Laboratories, Inc. (Corbett, OR). Mycotoxin concentrations were determined
at Romer Laboratories, Inc. (Union, MO) and the University of Missouri Veterinary
and Medical Diagnostic Laboratory (Columbia, MO).
2.2. Diet formulation, composition, and administration
All experimental diets were formulated by Purina Mills, LLC (St. Louis, MO) in
accordance with the standards of Purina Mills Labdiet Certiﬁed Rodent LabDiet
5002 (PMI 5002; PMI Nutrition International, 2009) and prepared at Purina Test-
Diet (Richmond, IN). The control diet was prepared with ground 091 maize grain,
the test diets with DP-ØØ4114-3 maize grain from glufosinate-treated plants
(4114GLU) or untreated plants (4114), and reference diets with maize grain from
32D78, 33N29, or 34P88 plants. The incorporation rate of maize grain in all diets
was 32% (wt/wt) which is within the standard range of corn for PMI 5002 diets.
Experimental diets were refrigerated upon arrival at DuPont Haskell Global Centers
for Health and Environmental Sciences (Haskell; Newark, DE). Fresh diet was sup-
plied weekly, and animals were fed the experimental diets for at least 91 consecu-
tive days.
2.3. Analytical characterization of experimental diets
Nutritional and contaminant analyses of all experimental diets were conducted
as described previously (MacKenzie et al., 2007; Malley et al., 2007; Appenzeller et
al., 2008, 2009). Homogeneity of all experimental diets was assessed in samples ob-
tained from the beginning, middle and end of diet production by analysis of
Cry34Ab1, Cry35Ab1, Cry1F, and PAT protein concentrations using antibody speciﬁc
ELISA. Stability of the 4114 and 4114GLU experimental diets was assessed by deter-
mination of the concentrations of the aforementioned proteins using antibody spe-
ciﬁc ELISA in samples collected at the time of ﬁrst use, following storage under
ambient conditions for 1 week and again at the end of the feeding trial (Week
13). Additionally, Cry1F protein activity was assessed in samples of the 4114 and
4114GLU diets obtained at the beginning of the feeding trial using a European corn
borer (ECB) bioassay as described previously (MacKenzie et al., 2007). As described
previously, the concentrations of the Cry34Ab1 and Cry35Ab1 proteins in maize
grain are not high enough to inhibit corn rootworm (CRW) growth, therefore their
biological in the test diet was not assessed (Malley et al., 2007).
2.4. Test system
Male and female Crl:CD (SD)IGS BR rats were obtained from Charles River Lab-
oratories, Inc., (Kingston, NY). Rats were housed individually in solid-bottom caging
containing Shepherd’s Cob + Plus™ bedding (Shepherd Specialty Papers, Water-
town, TN). The animal room was maintained at a temperature of 22 ± 4 C and a rel-
ative humidity of 30–70%, and ﬂuorescent lighting was provided on an approximate
12-h light/dark cycle. Tap water (UnitedWater Delaware, Wilmington, DE) was pro-
vided ad libitum to all rats. During the pretest period, animals were fed PMI Certiﬁed
Rodent LabDiet 5002 ad libitum. During the test period, animals were fed the 091,
4114, 4114GLU, 32D78, 33N29 or 34P88 diets ad libitum, except prior to blood col-
lection for clinical pathology evaluations and sacriﬁced when food, but not water,
was withheld. Rats approximately 6–8 weeks of age were assigned to groups
(n = 12/sex/group) following computerized randomization based on body weight.
Body weight and food consumption were determined for all rats twice during the
ﬁrst week of the test period and weekly thereafter. Food efﬁciency was calculated
for the same intervals from the food consumption and body weight data.
2.5. Clinical anatomic pathology
This feeding trial was conducted in accordance with the OECD 408 guideline for
a repeated dose 90-day oral toxicity study in rodents (OECD, 1998). All animals
were observed for mortality or moribundity twice daily and clinical observations
were conducted daily. Ophthalmology and neurobehavioral evaluations, including
a functional observational battery (FOB) and motor activity assessment, were con-
ducted for all rats once prior to exposure to the experimental diets and duringWeek
13 as reported previously (MacKenzie et al., 2007; Malley et al., 2007; Appenzeller
et al., 2008). After exposure to the experimental diets for 91–92 days (Males) and
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blood collection for clinical pathology evaluations and the scheduled sacriﬁce. Each
animal was weighed, anesthetized by inhalation of isoﬂurane, and sacriﬁced by
exsanguination. All rats were subjected to a complete gross pathology examination
during necropsy. Clinical and anatomic pathology assessments were conducted at
the end of the feeding interval (Week 14) following overnight fasting. Clinical
chemistry variables included serum aspartate aminotransferase (AST), alanine ami-
notransferase (ALT), sorbitol dehydrogenase (SDH), alkaline phosphatase (ALKP),
total bilirubin (BILI), urea nitrogen (BUN), creatinine (CREA), cholesterol (CHOL), tri-
glycerides (TRIG), glucose (GLUC), total protein (TP), albumin (ALB), globulin
(GLOB), calcium (CALC), inorganic phosphorus (IPHS), sodium (NA), potassium
(K), and chloride (CL). Hematology variables included red blood cell count (RBC),
hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), mean cor-
puscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC),
red cell distribution width (RDW), absolute reticulocyte count (ARET), platelet
count (PLT), white blood cell count (WBC), differential white blood cell count (ANEU
[neutrophils], ALYM [lymphocytes], AMON [monocytes], AEOS [eosinophils], ABAS
[basophils], and ALUC [large unstained cells]; prothrombin time (PT) and activated
partial thromboplastin time (APTT). Urinalysis variables included volume (VOL),
speciﬁc gravity (SG), pH, bilirubin, and urobilinogen (URO), and urine protein con-
centrations (UMTP), and urine osmolality (UOSM). Histopathologic analysis was
conducted on all rats from the 091, 4114 and 4114GLU maize grain groups. All
observations and analyses were conducted at DuPont Haskell and details related
to individual response variables, methods, tissues evaluated for microscopic pathol-
ogy evaluation were described in previous publications (MacKenzie et al., 2007;
Malley et al., 2007; Appenzeller et al., 2008) with the exception of the serial step
sectioning that was conducted on all available kidneys from the control, reference,
4114, and 4114GLU treatment groups as described by Eustis and co-workers (1994).2.6. Statistical analysis
Comparisons were designed to determine whether differences were attribut-
able to consumption of diets containing the 4114 and 4114GLU maize grain com-
pared to the control diet containing 091 near isogenic maize grain. Data from
male and female rats were analyzed separately. Groups of male and female rats
consuming diets containing maize grains from non-GM reference plants (32D78,
33N29, and 34P88) were included to assess variability of the response variables
evaluated in the current study. Preliminary tests to verify homogeneous variances
(Levene’s test; Levene, 1960) and normality (Shapiro–Wilks test; Shapiro and Wilk,
1965) were conducted for all continuous data. The use of contrasts retained the
within-group and between-group variances of the 091 control and reference groups
(32D78, 3N29 and 34P88). With the exception of motor activity and grip strength
data, if neither preliminary homogeneity test was signiﬁcant, a one-way analysis
of variance (ANOVA) was conducted using p-adjusted linear contrasts (Snedecor
and Cochran, 1967). If one or more of the preliminary tests was signiﬁcant, Dunn’s
Type 1 p-adjusted linear contrasts were used (Dunn, 1964). For motor activity and
grip strength data, if neither preliminary homogeneity test was signiﬁcant, a re-
peated measures analysis of variance (RANOVA) followed by linear contrasts was
conducted (Milliken and Johnson, 1984; Hocking, 1985). If one or more of the pre-
liminary tests was signiﬁcant, a normalizing, variance stabilizing transformation
followed by RANOVA (Milliken and Johnson, 1984) or a non-parametric test (Dunn,
1964) was conducted. Descriptive FOB data were analyzed using Fisher’s Exact test
(Fisher, 1985) with a Bonferroni-Holm correction (Holm, 1979). Where indicated,
historical control ranges were obtained from other studies conducted at Haskell
within the 10 years preceding this feeding trial using rats of similar species, age
and strain.1 Historical control HGB values range from 13.3 to 17.5 g/dl and historical control
hct values range from 42.1% to 55.0%.
2 Historical control ALKP values range from 43 to 158 U/L.3. Results
3.1. Characterization of maize grains and diets
All maize grains used in this study contained similar concentra-
tions of nutrients and contaminants and ELISA and event speciﬁc
PCR demonstrated that autonomy of the different maize lines
was properly controlled (data not shown). Similarly, the composi-
tion of the rodent diets were comparable regardless of the source
of the maize grains used to prepare them (Table 1). Quantitative
antibody speciﬁc ELISA testing for the Cry1F, Cry34Ab1, Cry
35Ab1, and PAT proteins was conducted on the 4114 and
4114GLU diets to demonstrate that the diets were blended homog-
enously at the beginning of the study and throughout the course of
the in life phase of the study to conﬁrm the stability of these pro-
teins (data not shown). Additionally, a bioassay conducted on
European corn borer larvae with the rodent diets at the beginning
and end of the in-life phase as described previously (MacKenzieet al., 2007), demonstrated that the Cry1F protein was biologically
active (data not shown).
3.2. Clinical and anatomic pathology
3.2.1. Body weights, food consumption and clinical observations
There were no differences in body weight or food consumption
between rats consuming diets containing maize grain from the 091
control compared with those containing the 4114 or 4114GLU
maize grain (Fig. 1 and 2). No adverse effects were observed in
any ophthalmological, clinical observations or neurobehavioral re-
sponse variables including the FOB and motor activity assessment
(data not shown).
3.2.2. Hematology and coagulation
The mean HGB and HCT values in males consuming the 4114
maize grain were greater (p < 0.05) than the values from males
consuming the 091 control maize grain (Table 2). While the differ-
ence was statistically signiﬁcant, this was not considered to be test
diet related or an adverse effect because the difference was small
in magnitude and all of the individual HGB (15.6–17.1 g/dL) and
HCT (45.8–50.9%) values from the 4114 maize grain group fell
within the range of the historical control data of the testing facil-
ity.1 There were no other statistical differences in the male rats
and there were no statistical differences in the hematology response
variables between females in the 4114 maize grain and the 091 con-
trol diet group (Table 3).
There were no statistically signiﬁcant differences in plasma
thromboplastin time (PT) and activated partial thromboplastin
time (APTT) in male or female rats consuming the 4114 maize
grain diet compared with the 091 control diet (Tables 2 and 3).
3.2.3. Clinical chemistry
No adverse or test diet-related differences in mean clinical
chemistry response variables were observed in male or female rats
fed the 4114 or 4114GLU test diets compared with the 091 control
group (Tables 4 and 5). There were, however, a number of statisti-
cal differences that were not considered test diet related or ad-
verse. The mean serum alkaline phosphatase (ALKP) activity was
higher (p < 0.05) in male rats from the 4114GLU group than the
091 Control group. However, all of the individual ALKP values from
the 4114GLU group (82–130 U/L) were within the range of histor-
ical control for similarly aged animals2 and there was no other indi-
cation of liver or other organ toxicity in the animals from that group.
Therefore, the difference was considered to be spurious, unrelated to
consumption of the test diet and not an adverse effect.
The mean creatinine (CREA) concentration was higher (p < 0.05)
in male rats from the 4114GLU group than in the 091 Control
group. However, there were no statistical differences between
the 091 control group and any of the other treatment groups
and, importantly, no correlative increases in blood urea nitrogen
(BUN) in males from the 4114GLU group and no other indicators
of kidney toxicity. Therefore, this difference was considered spuri-
ous and not related to consumption of the test diet.
Group mean potassium (K) was lower (p < 0.05) in female rats
from both the 4114 and 4114GLU groups. These statistical differ-
ences were also considered to be unrelated to consumption of
the test diets and non-adverse as they were minimal in magnitude
(94% and 92% of control, respectively) and were not associated
with differences in other serum electrolytes (sodium or chloride).
Further all of the individual K values in these groups were within
the range of individual values in the control or reference diet
Table 1
Nutritional composition of diets.
Nutritional analysis of rodent diets
Analytea,b 091 4114 4114GLU 32D78 33N29 34P88
Proximate analytes
Moisture (%) 11.4 10.9 10.8 11.1 10.8 11.2
Dry matter (%) 88.6 89.1 89.2 88.9 89.2 88.8
Crude protein (% FW) 20.55 20.55 20.64 20.67 20.31 20.3
Carbohydrate (% FW) 57.5 58.0 58.2 57.6 58.3 58.1
Crude fat (% FW) 5.39 5.46 5.36 5.34 5.40 5.40
Ash (% FW) 5.20 5.07 4.98 5.30 5.13 4.98
Crude ﬁber (% FW) 3.83 4.27 4.39 4.22 4.39 4.28
Neutral detergent ﬁber (% FW) 11.3 12.8 12.7 12.5 12.4 13.0
Acid detergent ﬁber (% FW) 5.50 6.15 6.69 5.85 6.09 6.19
Gross energy (kcal/100 g of FW) 401 405 404 402 406 405
Amino acids (%FW)
Arg 1.12 1.10 1.11 1.15 1.06 1.14
Cys 0.291 0.309 0.305 0.280 0.288 0.283
Gly 0.977 0.928 0.927 0.971 0.896 0.962
His 0.530 0.511 0.517 0.526 0.491 0.527
Ile 0.818 0.808 0.812 0.839 0.818 0.832
Leu 1.63 1.59 1.60 1.65 1.64 1.65
Lys 1.11 1.13 1.12 1.18 1.20 1.14
Met 0.446 0.411 0.435 0.413 0.454 0.398
Phe 0.965 0.929 0.949 0.964 0.898 0.960
Tyr 0.496 0.482 0.490 0.498 0.470 0.500
Thr 0.774 0.763 0.763 0.785 0.757 0.782
Trp 0.218 0.215 0.217 0.212 0.217 0.212
Val 0.964 0.950 0.948 0.985 0.955 0.976
Ser 0.975 0.955 0.962 0.992 0.953 0.984
Asp 1.86 1.98 1.98 2.03 2.04 1.90
Glu 3.74 3.81 3.79 3.96 4.01 3.80
Ala 1.03 1.03 1.03 1.07 1.07 1.05
Pro 1.33 1.25 1.25 1.33 1.30 1.30
a Additional nutrients measured: minerals (Ca, Cu, Fe, Mg, Mn, P, K, Na, Zn, Se, Co, Cl, I, Cr, F) and vitamins (folic acid, niacin, pantothenic acid, biotin, choline, A (retinol),
beta-carotene, B1 (thiamine), B2 (riboﬂavin), B6 (pyridoxine), B12, D3, beta-carotene, vitamin E as alpha-, beta, delta-, gamma-, and total tocopherol).
b Contaminants measured: heavy metals (As, Cd, Pb, Hg); mycotoxins (aﬂatoxins B1, B2, G1, and G2, zearalenone, oosporein, ergosine, ergotamine, ergocornine, ergo-
cryptine, ergocristine), deoxynivalenol, 3-acetyl-deoxynivalenol, 15-acetyl-deoxynivalenol, cyclopiazonic acid, fumonisin B1, B2, B3, moniliformin, T-2 toxin; and chemical
residues chlorinated hydrocarbons (aldrin, BHC-alpha, -beta, -delta, chlordane, DDT-related compounds, dieldrin, endrin, HCB, heptachlor, heptachlor epoxide, lindane,
methoxyclor, mirex, PCB) and organophosphates (diazinon, disulfoton, ethion, malathion, methyl parathion, parathion [ethyl], phorate [thimet], thiodan [endosulfan],
carbophenothion [trithion]).
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no differences in K values were present in male rats from the 4114
or 4114GLU groups.
3.2.4. Urinalysis
There were no statistical differences in mean urinalysis re-
sponse variables from rats consuming diets containing either
4114 or 4114GLU maize grain compared with rats consuming the
091 control diet (Table 6).
3.2.5. Organ weights
No diet-related organ weight ratio differences were observed in
either the 4114 or 4114GLU groups compared with the respective
male and female 091 control groups (Table 7). Following gross
evaluation and weighing of the total of 288 kidneys that were re-
moved, three were not available for processing into slides (one
from a female in the 091 Control group and the other two from a
female in the 4114GLU group) though they were weighed and doc-
umented as grossly normal at necropsy.
The only statistically signiﬁcant (p < 0.05) organ weight differ-
ence was a slightly lower mean absolute (11%) and relative (% brain
weight; 10%) epididymides weight in the 4114GLU males when
compared with the 091 control group (data not shown). This differ-
ence was considered spurious since there was no difference in the
mean relative (% body weight) epididymides weights (Table 7), the
091 control group mean absolute epididymides weight was 3–7%
higher than each of the reference group mean values, the 4114
group mean values of these variables were not statisticallydifferent from the values in the control group, and all mean epidid-
ymides weight and relative weight variables were within the range
observed in historical control animals (data not shown) and there
was no evidence of gross or microscopic changes in the
epididymides.
3.2.6. Pathology and histopathology
All but one of the rats survived to the scheduled sacriﬁce. One
female in one of the reference control groups (32D78) was ﬁrst ob-
served with a mammary gland mass (later determined to be ade-
nocarcinoma) on Day 66 of the study and sacriﬁced in extremis
because of the mass on Day 76. The tumor was considered
spontaneous.
There were no test diet related gross ﬁndings in rats consuming
either 4114 or 4114GLU maize grain.
A summary of the microscopic ﬁndings is presented in Table 8.
A number of histologic observations were noted in this study but
were background lesions and representative of what would be ex-
pected for rats of this age and strain. Furthermore, they were ran-
domly distributed indicating that there was no evidence of test diet
related adverse effects from consumption of diets containing either
4114 or 4114GLU maize grain.
Two males in the 4114 group were diagnosed with bilateral,
multiple, renal tubule tumors (RTT) of the amphophilic-vacuolar
type (AV) in association with multifocal atypical tubule hyperpla-
sia. In one animal there were 4–5 benign adenomas in each kidney
while the other had a benign adenoma in each kidney and a single
carcinoma in one kidney. The carcinoma was observed at gross
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days. 091, near-isogenic control maize; 4114, genetically modiﬁed (GM) maize, 4114GLU GM maize from herbicide-treated plants; 32D78, 33N29, and 354P88, non-GM
commercial reference maize.
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nosis of carcinoma was based on the presence of large amphophilic
and small basophilic cell types, large tumor size, and previous
characterization of this morphology as an AV tubule carcinoma.
The renal tubule tumors were morphologically typical of those de-
scribed previously for spontaneous AV tubule adenomas in Spra-
gue–Dawley rats from 90-day toxicity studies (Lanzoni et al.,2007; Hard et al., 1994, 2008). An independent panel of expert
pathologists was convened as a Pathology Working Group (PWG)
to evaluate the slides of the kidneys from these rats. The PWG
determined that the renal tubule tumors were spontaneous and
unrelated to consumption of the test diet. The ﬁndings of the panel
are described below in Section 4 and in greater detail in the accom-
panying paper (Hardisty et al., submitted for publication).
Table 2
Hematology and coagulation values for male rats (Day 92–93; mean ± SD).
091 4114 4114GLU 32D78 33N29 34P88
n = 12 n = 12 n = 12 n = 12 n = 12 n = 12
RBC (106/lL) 8.61 ± 0.27 8.81 ± 0.31 8.54 ± 0.36 8.88 ± 0.39 8.76 ± 0.27 8.88 ± 0.35
HGB (g/dL) 15.8 ± 0.4 16.3 ± 0.5⁄ 15.8 ± 0.4 16.0 ± 0.5 15.7 ± 0.5 15.9 ± 0.6
HCT (%) 45.8 ± 1.1 47.7 ± 1.7⁄ 46.2 ± 1.5 46.9 ± 1.6 46.0 ± 1.5 46.2 ± 1.9
MCV (fL) 53.3 ± 2.1 53.9 ± 2.0 54.1 ± 1.7 52.8 ± 1.4 52.5 ± 1.8 52.1 ± 1.2
MCH (pg) 18.4 ± 0.8 18.5 ± 0.6 18.6 ± 0.6 18.0 ± 0.6 18.0 ± 0.8 17.9 ± 0.5
MCHC (g/dL) 34.4 ± 0.6 34.3 ± 0.9 34.3 ± 0.9 34.1 ± 0.4 34.2 ± 0.7 34.4 ± 0.5
RDW (%) 12.7 ± 0.5 12.6 ± 0.7 12.9 ± 1.1 12.9 ± 0.7 12.8 ± 0.8 12.5 ± 0.5
ARET (103/lL) 175.53 ± 41.97 164.40 ± 24.52 199.19 ± 72.48 186.52 ± 33.64 159.29 ± 33.47 169.99 ± 52.01
PLT (103/lL) 1079 ± 71 1112 ± 261 1089 ± 76 1046 ± 87 1096 ± 91 1069 ± 95
WBC (103/lL) 9.71 ± 2.50 9.12 ± 1.76 8.56 ± 1.70 10.05 ± 2.47 8.96 ± 2.12 9.36 ± 1.79
ANEU (103/lL) 1.25 ± 0.31 1.20 ± 0.33 1.18 ± 0.38 1.47 ± 0.52 1.29 ± 0.45 1.11 ± 0.33
ALYM (103/lL) 8.00 ± 2.36 7.45 ± 1.66 7.03 ± 1.37 8.12 ± 2.36 7.24 ± 1.92 7.81 ± 1.70
AMON (103/lL) 0.20 ± 0.05 0.22 ± 0.10 0.16 ± 0.04 0.22 ± 0.06 0.22 ± 0.07 0.22 ± 0.06
AEOS (103/lL) 0.16 ± 0.05 0.16 ± 0.08 0.13 ± 0.06 0.16 ± 0.04 0.14 ± 0.05 0.15 ± 0.06
ABAS (103/lL) 0.02 ± 0.01 0.02 ± 0.01 0.01 ± 0.01 0.02 ± 0.02 0.02 ± 0.01 0.02 ± 0.01
ALUC (103/lL) 0.08 ± 0.04 0.06 ± 0.03 0.05 ± 0.02 0.06 ± 0.03 0.06 ± 0.03 0.05 ± 0.02
PT (s) 11.2 ± 0.9 11.3 ± 0.6 11.2 ± 0.8 11.1 ± 0.4a 11.2 ± 0.9 11.1 ± 0.7
APTT (s) 16.3 ± 1.5 16.8 ± 1.6 16.1 ± 1.6 17.1 ± 1.0a 16.4 ± 1.4 16.0 ± 1.6
⁄Statistically signiﬁcant difference from 091 control at p < 0.05 by one-way analysis of variance followed by linear contrasts.
Results are presented as mean ± SD.
Table 3
Hematology and coagulation values for female rats (Day 93–97; mean ± SD).
091 4114 4114GLU 32D78 33N29 34P88
n = 10 n = 12 n = 9 n = 10 n = 12 n = 10
RBC (x106/lL) 8.29 ± 0.32 8.23 ± 0.33 8.23 ± 0.25 8.32 ± 0.32 8.29 ± 0.37 8.32 ± 0.24
HGB (g/dL) 15.7 ± 0.6 15.7 ± 0.4 15.7 ± 0.4 16.0 ± 0.6 15.7 ± 0.5 15.9 ± 0.4
HCT (%) 45.5 ± 1.3 45.2 ± 1.2 44.9 ± 1.3 46.1 ± 1.8 45.2 ± 1.2 45.5 ± 1.2
MCV (fL) 55.0 ± 1.4 55.0 ± 2.5 54.5 ± 1.5 55.5 ± 2.7 54.6 ± 2.1 54.7 ± 1.7
MCH (pg) 19.0 ± 0.4 19.1 ± 0.6 19.1 ± 0.5 19.3 ± 0.7 19.0 ± 0.6 19.1 ± 0.6
MCHC (g/dL) 34.6 ± 0.6 34.7 ± 0.7 34.9 ± 0.5 34.8 ± 0.7 34.8 ± 0.9 34.9 ± 0.5
RDW (%) 11.3 ± 0.3 11.2 ± 0.5 11.2 ± 0.5 11.4 ± 0.3 11.4 ± 0.5 11.1 ± 0.4
ARET (103/lL) 164.77 ± 28.89 136.97 ± 28.44 151.68 ± 44.40 148.05 ± 35.67 163.48 ± 37.12 144.19 ± 23.24
PLT (103/lL) 1038 ± 101 932 ± 85 982 ± 106 944 ± 156 1015 ± 156 992 ± 118
WBC (103/lL) 5.69 ± 1.48 6.35 ± 1.54 7.11 ± 1.59 6.79 ± 1.30 6.67 ± 2.23 6.31 ± 1.31
ANEU (103/lL) 0.72 ± 0.35 0.92 ± 0.40 0.95 ± 0.37 0.82 ± 0.24 0.98 ± 0.38 0.92 ± 0.23
ALYM (103/lL) 4.72 ± 1.25 5.11 ± 1.21 5.87 ± 1.44 5.65 ± 1.37 5.35 ± 1.93 5.08 ± 1.28
AMON (103/lL) 0.12 ± 0.04 0.15 ± 0.09 0.13 ± 0.06 0.16 ± 0.04 0.16 ± 0.06 0.14 ± 0.05
AEOS (103/lL) 0.09 ± 0.04 0.12 ± 0.04 0.10 ± 0.02 0.11 ± 0.04 0.12 ± 0.06 0.11 ± 0.03
ABAS (103/lL) 0.01 ± 0.00 0.01 ± 0.01 0.01 ± 0.01 0.01 ± 0.00 0.01 ± 0.01 0.01 ± 0.00
ALUC (103/lL) 0.04 ± 0.01 0.04 ± 0.03 0.06 ± 0.02 0.04 ± 0.02 0.04 ± 0.02 0.05 ± 0.02
PT (s) 10.0 ± 0.3b 9.8 ± 0.4 9.9 ± 0.3a 10.0 ± 0.2c 9.9 ± 0.2 9.9 ± 0.2a
APTT (s) 13.9 ± 0.6b 14.1 ± 0.9 14.1 ± 0.8a 14.2 ± 0.8c 13.9 ± 0.6 14.3 ± 0.9a
There were no statistically signiﬁcant differences from 091 Control at p < 0.05.
an = 12; bn = 11; cn = 10; n < 12 because the EDTA whole blood sample was clotted and unusable for hematology analyses and whole blood was not available for the rat from
the 32D78 group that was sacriﬁced in extremis on Day 76.
Results are presented as means ± SD.
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During the development of GM crops, the transgenic proteins
that are to be present within them are subjected to numerous in
silico, in vitro, and in some cases animal studies to determine if they
are likely to present risk for allergenicity or toxicity (Codex, 2003;
Delaney et al., 2008). 4114 maize is a GM crop developed with a
transformation plasmid containing four expressed genes that en-
code four transgenic proteins: Cry1F, Cry34Ab1, Cry35Ab1, and
PAT. As discussed in prior publications, these proteins do not pres-
ent a risk for allergenicity or toxicity (Herman et al., 2003; Hérouet
et al., 2005; Ladics et al., 2006; Delaney et al., 2008; Juberg et al.,
2009).
Crops which contain transgenic proteins are also subjected to a
comprehensive assessment that focuses on demonstrating that
they are ‘‘as safe as’’ conventional crops with a history of safe
use (i.e., substantial equivalence; WHO, 1991, 1995). Whole grains
and processed fractions from numerous GM crops have also beenevaluated in subchronic rodent feeding studies to determine if
unintended adverse pleiotropic changes could have occurred as a
consequence of genetic modiﬁcation (Hammond et al., 2006a,b,
2004; MacKenzie et al., 2007; Malley et al., 2007; Appenzeller
et al., 2008; He et al., 2008; Healy et al., 2008; reviewed in Delaney,
2007). Of particular relevance to 4114 maize, no test diet related
adverse effects were observed in subchronic rodent feeding studies
conducted with maize grain from the GM crops in which the same
transgenic proteins are expressed (Malley et al., 2007; Appenzeller
et al., 2008, 2009).
The results from the current study support the safety of 4114
maize in that no test diet related adverse effects were observed
in rats consuming diets containing 4114 maize grain that was or
was not treated in the ﬁeld with glufosinate. As with other
90 day feeding studies with maize grains obtained from GM crops,
statistical differences were observed in a number of response vari-
ables between the 091 control group and the 4114 and 4114GLU
groups, but the differences were spurious and not test diet related
Table 4
Serum chemistry values for male rats (Day 92–93; mean ± SD).
091 4114 4114GLU 32D78 33N29 34P88
n = 12 n = 12 n = 12 n = 12 n = 12 n = 12
AST (U/L) 105 ± 23 97 ± 31 104 ± 31 102 ± 25 102 ± 33 106 ± 24
ALT (U/L) 36 ± 8 34 ± 7 35 ± 3 39 ± 8 46 ± 20 36 ± 7
SDH (U/L) 7.3 ± 4.6 8.9 ± 4.5 8.5 ± 6.8 10.3 ± 6.1 13.8 ± 7.6 7.9 ± 6.0
ALKP (U/L) 80 ± 21 77 ± 18 96 ± 13@ 93 ± 21 90 ± 20 82 ± 19
BILI (mg/dL) 013.±0.02 0.12 ± 0.02 0.12 ± 0.02 0.13 ± 0.02 0.13 ± 0.02 0.12 ± 0.02
BUN (mg/dL) 16 ± 2 16 ± 2 15 ± 2 16 ± 2 15 ± 2 15 ± 1
CREA (mg/dL) 0.37 ± 0.04 0.38 ± 0.04 0.44 ± 0.07⁄ 0.41 ± 0.06 0.41 ± 0.05 0.37 ± 0.05
CHOL (mg/dL) 70 ± 15 68 ± 14 62 ± 11 70 ± 13 65 ± 10 73 ± 19
TRIG (mg/dL) 70 ± 12 69 ± 23 68 ± 23 82 ± 34 66 ± 22 68 ± 19
GLUC (mg/dL) 126 ± 16 125 ± 10 134 ± 16 127 ± 14 135 ± 15 129 ± 12
TP (g/dL) 6.5 ± 0.4 6.6 ± 0.2 6.5 ± 0.3 6.7 ± 0.3 6.7 ± 0.2 6.5 ± 0.2
ALB (g/dL) 3.5 ± 0.2 3.5 ± 0.1 3.5 ± 0.1 3.5 ± 0.2 3.5 ± 0.1 3.4 ± 0.1
GLOB (g/dL) 3.1 ± 0.2 3.1 ± 0.2 3.0 ± 0.3 3.2 ± 0.2 3.2 ± 0.2 3.1 ± 0.2
CALC (mg/dL) 9.8 ± 0.4 9.7 ± 0.2 9.6 ± 0.3 9.9 ± 0.3 9.8 ± 0.2 9.7 ± 0.3
IPHS (mg/dL) 6.6 ± 0.4 6.4 ± 0.8 6.5 ± 0.8 6.8 ± 0.5 6.8 ± 0.7 6.7 ± 0.6
NA (mmol/L) 145.5 ± 5.1 144.5 ± 2.6 144.5 ± 1.8 146.0 ± 4.1 147.0 ± 4.9 146.5 ± 5.3
K (mmol/L) 5.25 ± 0.41 5.35 ± 0.63 5.03 ± 0.65 5.33 ± 0.48 5.31 ± 0.43 5.22 ± 0.45
CL (mmol/L) 107.7 ± 3.1 107.1 ± 1.9 106.9 ± 1.8 107.5 ± 3.0 108.4 ± 3.0 107.9 ± 4.1
⁄Statistically signiﬁcant difference from 091 control at p < 0.05 by one-way analysis of variance followed by linear contrasts.
@Statistically signiﬁcant difference from 091 control at p < 0.05 by Dunn’s Type I test for linear contrasts.
Results are presented as means ± SD.
Table 5
Serum chemistry values for female rats (Day 93–97; mean ± SD).
091 4114 4114GLU 32D78 33N29 34P88
n = 12 n = 12 n = 12 n = 11 n = 12 n = 12
AST (U/L) 117 ± 33a 109 ± 22 114 ± 35 104 ± 12 99 ± 13 123 ± 59
ALT (U/L) 42 ± 18a 36 ± 9 37 ± 12 34 ± 6 32 ± 6 41 ± 41
SDH (U/L) 13.2 ± 5.5b 8.4 ± 5.1 10.5 ± 5.1 9.1 ± 5.1 14.1 ± 7.4 14.3 ± 8.5
ALKP (U/L) 62 ± 17a 54 ± 17 59 ± 20 58 ± 18 64 ± 19 52 ± 24
BILI (mg/dL) 0.15 ± 0.02a 0.15 ± 0.03 0.15 ± 0.03 0.15 ± 0.03 0.14 ± 0.02 0.16 ± 0.03
BUN (mg/dL) 18 ± 2 17 ± 2 18 ± 2 18 ± 2 18 ± 2 18 ± 2
CREA (mg/dL) 0.49 ± 0.06a 0.46 ± 0.04 0.46 ± 0.06 0.46 ± 0.07 0.50 ± 0.05 0.47 ± 0.07
CHOL (mg/dL) 77 ± 15a 83 ± 13 79 ± 20 77 ± 10 86 ± 17 82 ± 11
TRIG (mg/dL) 60 ± 20a 59 ± 16 59 ± 17 56 ± 11 75 ± 23 63 ± 15
GLUC (mg/dL) 116 ± 15a 117 ± 7 121 ± 15 114 ± 11 120 ± 14 121 ± 15
TP (g/dL) 7.0 ± 0.4a 7.1 ± 0.4 7.1 ± 0.4 7.2 ± 0.5 7.0 ± 0.4 7.5 ± 0.5
ALB (g/dL) 4.0 ± 0.3a 4.0 ± 0.2 4.0 ± 0.2 4.0 ± 0.3 3.9 ± 0.2 4.2 ± 0.3
GLOB (g/dL) 3.0 ± 0.2a 3.1 ± 0.3 3.1 ± 0.2 3.2 ± 0.3 3.1 ± 0.3 3.3 ± 0.3
CALC (mg/dL) 10.3 ± 0.3a 10.2 ± 0.3 10.1 ± 0.3 10.3 ± 0.3 10.2 ± 0.4 10.4 ± 0.4
IPHS (mg/dL) 5.5 ± 1.3 5.0 ± 0.8 4.8 ± 0.5 5.6 ± 0.5 5.3 ± 0.6 5.2 ± 0.6
NA (mmol/L) 146.2 ± 0.33 142.7 ± 4.5 147.0 ± 6.8 148.9 ± 9.1 144.9 ± 3.8 145.1 ± 5.8
K (mmol/L) 5.09 ± 0.33 4.80 ± 0.27⁄ 4.70 ± 0.52⁄ 5.27 ± 0.32 4.90 ± 0.31 4.77 ± 0.25
CL (mmol/L) 108.5 ± 4.4 107.0 ± 3.4 110.2 ± 5.4 110.4 ± 6.9 107.5 ± 1.9 107.5 ± 4.8
an = 11; bn = 10.
⁄Statistically signiﬁcant difference from 091 control at p < 0.05 by one-way analysis of variance followed by linear contrasts.
Results are presented as means ± SD.
Table 6
Urinalysis values (mean ± SD).
091 4114 4114GLU 32D78 33N29 34P88
n = 12 n = 12 n = 12 n = 12 n = 12 n = 12
Males
UVOL (mL) 12.4 ± 11.8 12.2 ± 9.0 11.9 ± 9.4 13.7 ± 9.2 12.1 ± 8.3 11.5 ± 7.9
SG 1.040 ± 0.024 1.032 ± 0.015 1.035 ± 0.018 1.031 ± 0.018 1.033 ± 0.018 1.037 ± 0.020
pH 6.8 ± 0.4 6.8 ± 0.4 6.7 ± 0.3 7.0 ± 0.6 6.7 ± 0.2 6.9 ± 0.4
URO (EU/dL) 0.3 ± 0.2 0.2 ± 0.0 0.2 ± 0.0 0.3 ± 0.2 0.2 ± 0.0 0.3 ± 0.2
UMTP (mg/dL) 140 ± 83 132 ± 66 144 ± 66 132 ± 89 160 ± 95 147 ± 79
Females
UVOL (mL) 6.6 ± 4.1 6.4 ± 4.8a 3.9 ± 4.1a 6.9 ± 3.7a 8.1 ± 9.4 5.9 ± 4.3
SG 1.032 ± 0.013 1.036 ± 0.014a 1.052 ± 0.032a 1.031 ± -0.015a 1.034 ± 0.021 1.036 ± 0.024
pH 6.4 ± 0.4 6.4 ± 0.2a 6.6 ± 0.4a 6.5 ± 0.4a 6.5 ± 0.3 6.7 ± 0.5
URO (EU/dL) 0.2 ± 0.0 0.2 ± 0.0a 0.2 ± 0.0a 0.2 ± 0.0a 0.2 ± 0.0 0.2 ± 0.0
UMTP (mg/dL) 30 ± 15 37 ± 17a 66 ± 51a 30 ± 14a 33 ± 22 40 ± 33
an = 11.
There were no statistically signiﬁcant differences from 091 control at p < 0.05.
Results are presented as means ± SD.
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Table 7
Organ/body weight ratios (mean ± SD).
091 4114 4114GLU 32D78 33N29 34P88
n = 12 n = 12 n = 12 n = 12 n = 12 n = 12
Males
Body weight (ﬁnal, g) 552.7 ± 57.0 540.4 ± 35.4 532.5 ± 65.6 557.8 ± 61.5 542.3 ± 49.3 560.6 ± 55.1
Adrenals 0.012 ± 0.002 0.011 ± 0.001 0.012 ± 0.002 0.011 ± 0.001 0.012 ± 0.002 0.011 ± 0.002
Brain 0.387 ± 0.041 0.395 ± 0.024 0.400 ± 0.050 0.378 ± 0.037 0.401 ± 0.038 0.381 ± 0.033
Epididymides 0.292 ± 0.030 0.284 ± 0.030 0.272 ± 0.032 0.272 ± 0.050 0.284 ± 0.021 0.280 ± 0.039
Heart 0.293 ± 0.029 0.285 ± 0.014 0.302 ± 0.029 0.295 ± 0.021 0.290 ± 0.022 0.294 ± 0.027
Kidneys 0.595 ± 0.051 0.586 ± 0.047a 0.584 ± 0.055 0.598 ± 0.059 0.592 ± 0.051 0.616 ± 0.058
Liver 2.594 ± 0.293 2.603 ± 0.175 2.540 ± 0.248 2.678 ± 0.190 5.594 ± 0.180 2.605 ± 0.180
Spleen 0.165 ± 0.036 0.154 ± 0.019 0.147 ± 0.018 0.144 ± 0.015 0.145 ± 0.026 0.156 ± 0.024
Testes 0.647 ± 0.082 0.682 ± 0.083 0.664 ± 0.090 0.626 ± 0.050 0.652 ± 0.039 0.657 ± 0.059
Thymus 0.074 ± 0.012 0.067 ± 0.014 0.086 ± 0.014 0.081 ± 0.022 0.077 ± 0.020 0.078 ± 0.015
Females
Body weight (ﬁnal, g) 288.3 ± 29.8 291.6 ± 33.6 265.1 ± 17.1 285.0 ± 35.0a 286.0 ± 26.6 289.0 ± 25.6
Adrenals 0.023 ± 0.004 0.023 ± 0.004 0.023 ± 0.004 0.026 ± 0.004a 0.023 ± 0.004 0.023 ± 0.004
Brain 0.674 ± 0.058 0.655 ± 0.062 0.708 ± 0.047 0.687 ± 0.069a 0.672 ± 0.061 0.653 ± 0.065
Heart 0.348 ± 0.025 0.358 ± 0.053 0.367 ± 0.018 0.354 ± 0.037a 0.352 ± 0.040 0.367 ± 0.040
Kidneys 0.631 ± 0.059 0.648 ± 0.067 0.681 ± 0.050 0.659 ± 0.071a 0.638 ± 0.038 0.636 ± 0.053
Liver 2.483 ± 0.189 2.536 ± 0.175 2.656 ± 0.209 2.569 ± 0.221a 2.553 ± 0.201 2.581 ± 0.137
Ovaries 0.049 ± 0.007 0.047 ± 0.010 0.052 ± 0.007 0.057 ± 0.006a 0.049 ± 0.008 0.048 ± 0.010
Spleen 0.179 ± 0.026 0.173 ± 0.026 0.195 ± 0.030 0.171 ± 0.014a 0.180 ± 0.024 0.180 ± 0.023
Thymus 0.105 ± 0.027 0.115 ± 0.018 0.120 ± 0.024 0.115 ± 0.026a 0.112 ± 0.019 0.106 ± 0.023
Uterus 0.273 ± 0.095 0.241 ± 0.072 0.233 ± 0.070 0.235 ± 0.100a 0.224 ± 0.066 0.243 ± 0.073
an = 11.
There were no statistically signiﬁcant differences from 091 Control at p < 0.05.
Results are presented as means ± SD.
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2007; Appenzeller et al., 2008, 2009; Healy et al., 2008).
Two males from the 4114 group were diagnosed with bilateral,
multiple, renal tubule tumors (RTT) of the amphophilic-vacuolar
type (AV) in association with multifocal atypical tubule hype rpla-
sia. Following the initial observation from the study pathologist,
step sectioning of the remaining kidney tissues was conducted
for all available rats from the 091 control group, the three reference
maize grain groups (32D78, 33N29, and 34P88) as well as the rats
from the 4114 and 4114GLU treatment groups as recommended by
Eustis and colleagues (1994). Slides produced from the step sec-
tioning conﬁrmed the original ﬁndings of AV tumors in the two
male rats from the 4114 group but did not note anything other
than background lesions in any of the kidneys from any of the
other treatment groups (data not shown). A Pathology Working
Group was later convened to review the kidney slides from the
091, 4114, and 4114GLU groups and they too conﬁrmed the ﬁnd-
ings and concluded that these tumors were spontaneous and not
related to exposure to the 4114 maize grain. The methods and con-
clusions of the Pathology Working Group are summarized in a sep-
arate paper (Hardisty et al., submitted for publication).
The ﬁnding of spontaneous renal tubule tumors in rats has been
observed in previous short term studies and in each case the tu-
mors were considered unrelated to treatment (Hard et al., 1994;
Hall et al., 2007; Lanzoni et al., 2007). This determination was
based on the distinctive histological proﬁle of these tumors that
clearly differentiates them from chemically induced renal tumors
(Hard et al., 2008). Tubular epithelial cells were enlarged with in-
creased amphophilic cytoplasm, sometimes piling up within the
conﬁnes of the tubule. The distinction between hyperplastic le-
sions with papillary projections and small adenomas was some-
times difﬁcult to make as the lesions appeared to represent a
proliferative continuum. One renal tubule tumor was diagnosed
as a carcinoma based on the presence of both large amphophilic
and small basophilic cells, large tumor size, and previous charac-
terization of this morphology as an AV tubule carcinoma (Lanzoni
et al., 2007; Hard et al., 2008). There was no evidence of nephrotox-
icity in any kidneys in this study, including the kidneys with the
atypical tubule hyperplasia and AV tumors. The benign adenomaswere morphologically typical of those described previously for
spontaneous AV tubule adenomas in Sprague–Dawley rats from
90-day toxicity studies and in longer term rodent feeding studies
(Hard et al., 1994, 2008; Hall et al., 2007; Lanzoni et al., 2007).
As noted in Section 3, one animal in a reference group (32D78)
was euthanized prior to the scheduled sacriﬁce because of an
ulcerated mammary gland mass which was later diagnosed as a
mammary gland adenocarcinoma. Although mammary gland ade-
nocarcinomas are not common in 90-day feeding studies they have
been reported to occur spontaneously in animals as young as
10 weeks of age (Oishi et al., 1995) and they are common in older
rats (Son, 2004; Son and Gopinath, 2004; Brix et al., 2005). There-
fore, this tumor was considered incidental and typical of this neo-
plasm that occurs naturally in laboratory rats and not related to
dietary exposure to 4114 maize grain because the animals in that
group consumed diets containing commercially available non-
GM maize grain (Giknis and Clifford, 2004).
The renal tubule adenomas and carcinoma and renal tubule
hyperplasia observed in the two male rats from the 4114 group
were spontaneous lesions unrelated to consumption of the test diet
because: (i) they were morphologically identical to speciﬁc hyper-
plastic and neoplastic lesions previously reported to occur sponta-
neously in multiple rat strains, including Crl:CD(SD)IGS rats; (ii)
there are no reports of an increase in AV tubule neoplasms as a re-
sult of test material exposure (Hard et al., 2008); (iii) the young age
of onset for the tumors in these two rats is typical of spontaneous
renal tumors in genetically susceptible rats and not characteristic
of chemically-induced renal tumors; and (iv) there was no evi-
dence of cytotoxic changes consistent with pre-neoplastic tubular
epithelial cytotoxicity (i.e., nephrotoxicity), as is typical of chemi-
cally-induced renal tubular neoplasia. In addition to the morphol-
ogy of the tumors themselves, the fact that not tumors were
observed in the 4114GLU males or in either female treatment
group and there were no preneoplastic changes observed in any
of the laboratory animals supports the conclusion that the tumors
that were observed were not treatment related.
The pre-commercial safety assessment of biotech crops includes
an assessment of the transgenic proteins for acute toxicity and
similarity to allergenic proteins as well as an evaluation of the
Table 8
Summary of microscopic incidence ﬁndings.
Tissue Finding Male Female
091 4114 4114GLU 091 4114 4114GLU
Cecum Inﬂammation, mucosal 0 0 0 1 1 2
Minimal [0] [0] [0] [1] [0] [1]
Mild [0] [0] [0] [0] [1] [1]
Eyes Degeneration/atrophy, retinal, multifocal 1 0 1 0 0 0
Minimal [1] [0] [0] [0] [0] [0]
Mild [0] [0] [1] [0] [0] [0]
Fold/rosette, retinal, minimal 1 0 1 0 0 0
Heart Cardiomyopathy, minimal 3 2 2 0 1 1
Kidney Aggregates, lymphoid 5 5 6 4 4 4
Minimal [5] [5] [5] [4] [4] [3]
Mild [0] [0] [1] [0] [0] [1]
Atrophy, focal tubular, minimal 1 2 0 0 0 2
Chronic progressive nephropathy, minimal 9 11 8 1 4 3
Cysts, tubular 1 3 0 1 0 1
Minimal [1] [2] [0] [0] [0] [1]
Mild [0] [1] [0] [1] [0] [0]
Hydronephrosis, unilateral 1 1 1 0 0 0
Minimal [0] [1] [1] [0] [0] [0]
Mild [1] [0] [0] [0] [0] [0]
Hyperplasia, atypical, multifocal, bilateral 0 2 0 0 0 0
Mild [0] [1] [0] [0] [0] [0]
Moderate [0] [1] [0] [0] [0] [0]
Pyelonephritis, unilateral, minimal 0 0 0 0 2 1
Adenoma, tubular, amphophilic-vacuolar, multiple, bilateral, benign, primary, incidental 0 2 0 0 0 0
Carcinoma, tubular, amphophilic-vacuolar, multiple, unilateral, malignant without
metastasis, primary, incidental
0 1 0 0 0 0
Liver Fatty change, median cleft 3 1 2 2 3 2
Minimal [3] [1] [2] [2] [1] [2]
Mild [0] [0] [0] [0] [2] [0]
Fatty change, periportal, minimal 1 1 0 1 0 0
Mononuclear cell inﬁltrate, minimal 8 8 7 6 9 5
Lungs Histiocytosis, alveolar, minimal 1 1 1 1 1 0
Inﬂammation, perivascular, minimal 0 0 0 1 1 1
Mandibular lymph
node
Erythrocytosis/hemosiderosis, sinus 3 1 0 2 0 0
Minimal [2] [0] [0] [2] [0] [0]
Mild [1] [1] [0] [0] [0] [0]
Hyperplasia, lymphoid follicular 1 1 3 2 2 1
Minimal [1] [1] [1] [2] [1] [1]
Mild [0] [0] [2] [0] [1] [0]
Hyperplasia, plasma cell 1 3 0 1 1 1
Minimal [1] [1] [0] [1] [1] [1]
Mild [0] [2] [1] [0] [0] [0]
Nose Inﬂammation, turbinates, minimal 2 2 1 0 1 0
Pancreas Atrophy, lobular 2 0 0 0 0 0
Minimal [1] [0] [0] [0] [0] [0]
Mild [1] [0] [0] [0] [0] [0]
Inﬂammation, multifocal, minimal 1 1 0 0 0 0
Peyer’s patch Mineralization 0 0 0 2 0 0
Minimal [0] [0] [0] [1] [0] [0]
Mild [0] [0] [0] [1] [0] [0]
Pharynx Inﬂammation 1 1 0 0 0 3
Minimal [1] [1] [0] [0] [0] [2]
Mild [0] [0] [0] [0] [0] [1]
Pituitary gland Cyst, craniopharyngeal, minimal 0 0 0 0 1 1
Prostate Aggregates, lymphoid 9 7 8 – – –
Minimal [7] [5] [6] – – –
Mild [2] [2] [2] – – –
Teeth Inﬂammation, periodontal 4 3 6 4 5 9
Minimal [2] [3] [4] [4] [5] [9]
Mild [2] [0] [2] [0] [0] [0]
Thymus Hyperplasia, epithelial, minimal 1 0 0 0 2 2
Thyroid Cysts, follicular 1 2 0 0 0 0
Minimal [1] [0] [0] – – –
Mild [0] [2] [0] – – –
Cysts, ultimobranchial 2 1 1 1 5 0
Hypertrophy, follicular cell, minimal 1 2 2 0 0 0
Uterus Dilatation – – – 7 3 2
Minimal – – – [0] [0] [1]
Mild – – – [6] [3] [1]
Moderate – – – [1] [0] [0]
Table reports microscopic ﬁndings where incidence was greater than 1 per treatment group in either the 091, 4114, or 4114GLU treatment groups from a total of 51 tissues
examined in each treatment group. The grading (e.g., minimal, mild) of the ﬁnding varied, the incidence of each grade is presented in brackets.
B. Delaney et al. / Food and Chemical Toxicology 53 (2013) 417–427 425
426 B. Delaney et al. / Food and Chemical Toxicology 53 (2013) 417–427genetically-modiﬁed crop for unintended changes (i.e., pleiotropic
effects) by compositional analyses and performance in animal
feeding studies. In this study the nutritional performance of bio-
tech maize grain as compared to conventional maize grain was
examined and the 4114 maize grain was evaluated for possible
unintended changes in dietary toxicity.
5. Conclusions
The results reported in this paper support the conclusion that
grain from 4114 maize is as safe and nutritious as maize grain from
conventional maize crops.
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